Newcastle scientist named as gastroenterology ‘rising star’
A Newcastle researcher has been named as one of the most promising, emerging scientists in Europe for his work in the field of gastroenterology.
Chris Lamb has been named as a Rising Star 2023 by United European Gastroenterology (UEG), the leading non-profit organisation for excellence in digestive health in Europe.
Chris is a Clinical Senior Lecturer and Honorary Consultant in Gastroenterology within Immunity and Inflammation at the Translational & Clinical Research Institute at Newcastle University. He is also an emerging leader in the NIHR Newcastle BRC’s liver disease, multimorbidity and lifestyle research theme and an honorary gastroenterologist at Newcastle Hospitals.
UEG awards this prize every year to the most promising, emerging scientists based on a track record of international quality research and developing scientific independence.
“I’m proud of being able to work with patients, clinicians and scientists and love the unique job that I have. In my research role I work to understand the biomedical mechanisms behind treatments for inflammatory bowel disease. I hope that my research will help patients to receive the best treatments for them at the right time in the course of their Crohn’s disease or ulcerative colitis.”
“I wish to inspire others that academia is accessible at all career stages by demonstrating that a diverse research portfolio, grounded in patient experience and recognition of the unmet medical need, can lead to patient benefit. I wish to act as a role model by describing my experience of clinical and laboratory research so others realise “I can do that!””
Chris is currently chief investigator for IBD-RESPONSE, a UK-wide study which aims to provide a better understanding of the relationship between the gut microbiome and treatment outcomes in inflammatory bowel disease.
Find out more about IBD-RESPONSE
Find out more about Chris and his areas of work
Find out more about our liver disease, multimorbidity and lifestyle research theme